DRKS00029372招募中未知
euromodulation in Obesity - NiObe
Charité - Universitätsmedizin Berlin,Klinik für Endokrinologie, Diabetes und Stoffwechselmedizin0 个研究点目标入组 60 人开始时间: 2022年7月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Obesity (BMI > 30 kg/m²)
排除标准
- •Pregnancy and lactation, photosensitive epilepsy, electronic/ferromagnetic implantats, Diabetes mellitus Type 1/2
研究者
相似试验
招募中
不适用
etherlands Epidemiology of Obesity studyobesity-related diseases100184241001331710006436NL-OMON55863eids Universitair Medisch Centrum6,000
已完成
不适用
nbiased DECONvolution of obesityE66ObesityDRKS00015814niversitätsklinikum FreiburgKlinik für Allgemein- und Viszeralchirurgie50
进行中（未招募）
1 期
An investigation into the modulation of obesity associated monocyte/macrophage function, vascular inflammation and insulin resistance by PPAR agonist treatmentThe proposed study will investigate early indicators of cardiovascular disease and diabetes in healthy, obese men without a family history of diabetes and whether these are changed by treatment with the common PPAR agonists fenofibrate andpioglitazone.EUCTR2006-004296-35-GBThe Royal Group of Hospitals, Belfast Health and Social Care Trust80
招募中
不适用
WAnTeD: Path to obesity therapy in Germany - an online surveyE66ObesityDRKS00032638Hochschule für Angewandte Wissenschaften Fulda1,000
Unknown
4 期
Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in ObesityObesityNCT03710460University of Guadalajara33